Merck Shares Drop After Anti-Clotting Drug Trials Curtailed

The drug was one of the more attractive assets Merck acquired through its purchase of Schering-Plough.

Source: http://feedproxy.google.com/~r/wsj/health/feed/~3/TVltcA8-SrY/

athletes health migraines teeth